Penumbra PEN - Options Chain | ADVFN

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NYSE
Penumbra Inc (PEN)
Penumbra Inc (PEN) Options

Penumbra Inc (PEN)

204.41

-1.09

(-0.53%)

Closed April 27 4:00PM

Delayed by 15 minutes

204.41

0.00

(0.00%)

After Hours: 7:18PM

Delayed by 15 minutes

PEN Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
150.00	53.80	57.40	0.00	55.60	0.00	0.00 %	0	0	-
155.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
160.00	43.50	47.20	0.00	45.35	0.00	0.00 %	0	0	-
165.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
170.00	34.00	37.60	0.00	35.80	0.00	0.00 %	0	0	-
175.00	30.10	34.00	0.00	32.05	0.00	0.00 %	0	0	-
180.00	25.60	29.40	0.00	27.50	0.00	0.00 %	0	0	-
185.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
200.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
210.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
220.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	0.20	1.60	1.55	0.90	0.00	0.00 %	0	431	-
250.00	0.15	0.80	1.52	0.475	0.00	0.00 %	0	58	-
260.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
270.00	0.00	2.15	0.00	0.00	0.00	0.00 %	0	0	-
280.00	0.00	1.80	0.00	0.00	0.00	0.00 %	0	0	-
290.00	1.35	1.65	1.35	1.50	0.00	0.00 %	0	1	-

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
150.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
155.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
160.00	0.20	4.30	0.00	2.25	0.00	0.00 %	0	0	-
165.00	0.25	3.80	0.00	2.025	0.00	0.00 %	0	0	-
170.00	0.25	4.00	0.00	2.125	0.00	0.00 %	0	0	-
175.00	0.90	2.00	0.00	1.45	0.00	0.00 %	0	0	-
180.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
185.00	2.30	4.70	3.20	3.50	0.00	0.00 %	0	205	-
190.00	3.90	5.10	4.10	4.50	0.00	0.00 %	0	2	-
195.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
200.00	7.50	8.10	7.30	7.80	0.30	4.29 %	1	11	4/26/2024
210.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
220.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	33.80	37.10	21.80	35.45	0.00	0.00 %	0	5	-
250.00	43.00	46.80	0.00	44.90	0.00	0.00 %	0	0	-
260.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
270.00	63.10	67.40	48.54	65.25	0.00	0.00 %	0	0	-
280.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
290.00	83.00	87.50	0.00	85.25	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M

@LaughinPaulRyan

@LaughinPaulRyan 3 years ago

... ALL NEWS IS GOOD? ... $PEN

CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

@LaughinPaulRyan

@LaughinPaulRyan 3 years ago

QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company

@LaughinPaulRyan

@LaughinPaulRyan 3 years ago

Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients

davidsson10

davidsson10 3 years ago

https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

@LaughinPaulRyan

@LaughinPaulRyan 3 years ago

... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020

TREND1

TREND1 9 years ago

IPO INFO

http://www.marketwatch.com/tools/ipo-calendar

TREND1

TREND1 9 years ago

IPO NOW HAS SYMBOL
Penumbra PEN

TREND1

TREND1 9 years ago

IPO should be out soon.
no symbol yet.

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions